Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

Bruce Neal^{1

2}, Vlado Perkovic¹, David R Matthews³

Affiliations

Free article

Comment

Bruce Neal et al. N Engl J Med. 2017.

Free article

. 2017 Nov 23;377(21):2099.

doi: 10.1056/NEJMc1712572.

Bruce Neal^{1

2}, Vlado Perkovic¹, David R Matthews³

No abstract available

Comment on

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Baglioni P. Baglioni P. N Engl J Med. 2017 Nov 23;377(21):2097-8. doi: 10.1056/NEJMc1712572. N Engl J Med. 2017. PMID: 29182247 No abstract available.
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Fernández‑Balsells MM, Sojo-Vega L, Ricart-Engel W. Fernández‑Balsells MM, et al. N Engl J Med. 2017 Nov 23;377(21):2098. doi: 10.1056/NEJMc1712572. N Engl J Med. 2017. PMID: 29182249 No abstract available.
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Rajagopalan S, Brook R. Rajagopalan S, et al. N Engl J Med. 2017 Nov 23;377(21):2098-9. doi: 10.1056/NEJMc1712572. N Engl J Med. 2017. PMID: 29182250 No abstract available.